tiprankstipranks
Inmune Bio (INMB)
NASDAQ:INMB
US Market
INMB
Inmune Bio
RESEARCH TOOLSreports

Inmune Bio (INMB) Income Statement

876 Followers

Inmune Bio Income Statement

Last quarter (Q4 2025), Inmune Bio's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q4, Inmune Bio's net income was $-5.26M. See Inmune Bio’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 50.00K$ 14.00K$ 155.00K$ 374.00K$ 181.00K
Gross Profit
$ 50.00K$ 14.00K$ 155.00K$ 374.00K$ 181.00K
Operating Expenses
$ 30.92M$ 42.65M$ 29.90M$ 26.32M$ 29.33M
Depreciation and Amortization
$ 84.00K$ 553.00K$ 29.74M$ 25.95M$ 29.15M
EBITDA
$ -30.79M$ -42.08M$ 0.00$ 0.00$ 0.00
Operating Income
$ -30.87M$ -42.63M$ -29.74M$ -25.95M$ -29.15M
Other Income/Expenses
$ -15.06M$ 553.00K$ -267.00K$ -1.35M$ -1.19M
Pretax Income
$ -45.93M$ -42.08M$ -30.01M$ -27.30M$ -30.34M
Net Income
$ -45.93M$ -42.08M$ -30.01M$ -27.30M$ -30.34M
Per Share Metrics
Basic EPS
$ 0.00$ -2.11$ -1.67$ -1.52$ -1.88
Diluted EPS
$ 0.00$ -2.11$ -1.67$ -1.52$ -1.88
Weighted Average Shares Outstanding
 26.59M 19.94M 17.98M 17.93M 16.13M
Weighted Average Shares Outstanding (Diluted)
 26.59M 19.94M 17.98M 17.93M 16.13M
Currency in USD

Inmune Bio Earnings and Revenue History